Why the study?
IKKβ suppresses mitochondrial injury in doxorubicin cardiomyopathy, but the underlying mechanism remained undefined.
Does IKKβ-mediated phosphorylation of MFN2 prevent doxorubicin-induced mitochondrial injury and cell death in cardiac myocytes?
Population
Cardiac myocytes treated with doxorubicin
Comparison
IKKβ or MFN2S53D gain of function vs controls or mutant variants
Design
Preclinical in vitro mechanistic study
Authors
Loading...
May inform cardioprotective strategies in doxorubicin cardiomyopathy; hypothesis-generating for IKKβ-MFN2 axis modulation.
Does IKKβ-mediated phosphorylation of MFN2 prevent doxorubicin-induced mitochondrial injury and cell death in cardiac myocytes?
IKKβ protects against doxorubicin-induced cardiomyopathy by phosphorylating and stabilizing MFN2, revealing a novel survival pathway.
Guberman et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: